相似文献
1
[2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
Internist (Berl). 1996 Sep;37(9):944-9; discussion 949.
2
[Do other proton pump blockers have advantages over Antra (omeprazole)?].
Internist (Berl). 1996 Sep;37(9):936-7.
3
Proton-pump inhibitors: three of a kind?
Lancet. 1997 Jun 7;349(9066):1637-8. doi: 10.1016/s0140-6736(05)62629-3.
4
[Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].
Ugeskr Laeger. 1996 Mar 18;158(12):1695-7.
5
[Drug interactions. Proton pump inhibitors II].
Internist (Berl). 1998 Sep;39(9):978-9.
6
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. doi: 10.1016/s1086-5802(16)31036-1.
7
Recurrent anaphylaxis linked to pantoprazole.
J Allergy Clin Immunol. 2004 Oct;114(4):975-7. doi: 10.1016/j.jaci.2004.05.068.
8
[Drug interactions. Proton pump inhibitors. 1].
Internist (Berl). 1998 Aug;39(8):874-5.
9
[Are proton pump inhibitors safe?].
Internist (Berl). 1994 Dec;35(12):1137-46.
10
Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.
Dig Dis Sci. 2001 May;46(5):993-6. doi: 10.1023/a:1010745624971.
Zotero 插件